Related references
Note: Only part of the references are listed.Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2020)
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Steven D. Nathan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Johan van Cleemput et al.
ADVANCES IN THERAPY (2019)
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
Rachel K. Putman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
Joseph Jacob et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Pulmonary Function Tests for the Generalist: A Brief Review
Timothy M. Dempsey et al.
MAYO CLINIC PROCEEDINGS (2018)
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views
Toby M. Maher et al.
RESPIRATION (2018)
Matrix abnormalities in pulmonary fibrosis
Chandak Upagupta et al.
EUROPEAN RESPIRATORY REVIEW (2018)
A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers
C. C. Moor et al.
RESPIRATORY RESEARCH (2018)
What can we learn from pulmonary function testing in heart failure?
Helgo Magnussen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis
Kerri A. Johannson et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis
Miya O. Paterniti et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis
Anne-Marie Russell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Steven D. Nathan et al.
THORAX (2016)
Accuracy and Quality of Spirometry in Primary Care Offices
Matthew J. Hegewald et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis
Deborah Assayag et al.
RESPIRATORY MEDICINE (2015)
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials
Michael T. Durheim et al.
LANCET RESPIRATORY MEDICINE (2015)
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
R. Gisli Jenkins et al.
LANCET RESPIRATORY MEDICINE (2015)
Predicting Pulmonary Fibrosis Disease Course From Past Trends in Pulmonary Function
Shelley L. Schmidt et al.
CHEST (2014)
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Roland M. du Bois et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis
Takanori Akagi et al.
RESPIRATORY MEDICINE (2009)
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
V Cottin et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
The clinical course of patients with idiopathic pulmonary fibrosis
FJ Martinez et al.
ANNALS OF INTERNAL MEDICINE (2005)
Weight loss, not aerobic exercise, improves pulmonary function in older obese men
CJ Womack et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2000)
Share Paper
